Bradley F Boeve researcher
Boeve, Bradley F.
VIAF ID: 271823455 (Personal)
Permalink: http://viaf.org/viaf/271823455
Preferred Forms
- 100 1 _ ‡a Boeve, Bradley F.
-
-
-
-
-
-
- 100 1 _ ‡a Boeve, Bradley F.
-
- 100 1 _ ‡a Boeve, Bradley F.
- 100 1 _ ‡a Boeve, Bradley F.
- 100 0 _ ‡a Bradley F Boeve ‡c researcher
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
The behavioral neurology of dementia | |
Frontotemporal dementias : emerging milestones of the 21st century | |
Otępienie niealzheimerowskie. | |
Podstawy prawidłowego rozpoznawania łagodnych zaburzeń poznawczych i podstawowych podtypów otępienia | |
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS | |
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies | |
The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease | |
Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment | |
Rozpoznawanie i leczenie otępienia z ciałami Lewy'ego : czwarte stanowisko DLB Consortium = Diagnosis and management of dementia with Lewy bodies : fourth consensus report of the DLB Consortium | |
Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis | |
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy | |
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | |
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease | |
Shapes of the trajectories of 5 major biomarkers of Alzheimer disease | |
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease | |
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin | |
Sleep disturbance in dementia with Lewy bodies and Alzheimer's disease: a multicenter analysis | |
SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder | |
Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging | |
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. | |
Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series | |
The strong presence of REM sleep behavior disorder in PD: clinical and research implications. | |
Submentalis Rapid Eye Movement Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy | |
Successful aging: definitions and prediction of longevity and conversion to mild cognitive impairment | |
Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study | |
Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND | |
Symmetric corticobasal degeneration (S-CBD). | |
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). | |
Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum. | |
Tau Mutations as a Novel Risk Factor for Cancer-Letter | |
Tau-negative amnestic dementia masquerading as Alzheimer disease dementia. | |
Tau-positron emission tomography correlates with neuropathology findings | |
TDP-43 AMPLIFIES MEMORY LOSS AND HIPPOCAMPAL ATROPHY IN ALZHEIMER'S DISEASE | |
TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia | |
TDP-43 is a key player in the clinical features associated with Alzheimer's disease | |
TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease | |
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease | |
Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. | |
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. | |
Testing normal older people three or four times at 1- to 2-year intervals: defining normal variance. | |
Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers | |
Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD. | |
Timeline of REM Sleep Behavior Disorder in Overt Alpha-Synucleinopathies | |
TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia | |
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia | |
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. | |
Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS | |
Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study | |
Transient Epileptic Amnesia: A Treatable Cause of Spells Associated With Persistent Cognitive Symptoms | |
The treatment of parasomnias with hypnosis: a 5-year follow-up study | |
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease | |
TREM2 p.R47H substitution is not associated with dementia with Lewy bodies | |
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia | |
TYROBP genetic variants in early-onset Alzheimer's disease. | |
Understanding the diagnostic capabilities of cognitive tests. | |
Undetectable CSF hypocretin-1 in "Hashimoto's encephalopathy" associated with coma | |
Uptake of AV-1451 in meningiomas. | |
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. | |
Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy | |
Utility of the DRS for predicting problems in day-to-day functioning | |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium | |
Validation of consensus panel diagnosis in dementia | |
Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. | |
Vascular Dementia in a Population-Based Autopsy Study | |
Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment | |
Very early semantic dementia with progressive temporal lobe atrophy: an 8-year longitudinal study | |
Visual hallucinations in posterior cortical atrophy | |
Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations | |
Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia | |
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN | |
What is the quality of life in the oldest old? | |
White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging | |
White-matter integrity on DTI and the pathologic staging of Alzheimer's disease. | |
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease | |
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia | |
Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly | |
Young-onset dementia: demographic and etiologic characteristics of 235 patients | |
Zespoły otępienne przebiegajace z parkinsonizmem | |
β-Amyloid PET and neuropathology in dementia with Lewy bodies |